DXC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DXC is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has weak technical momentum, mixed-to-bearish fundamentals, and no strong proprietary buy signal. Based on the data, the better move is to hold off rather than buy immediately.
DXC’s trend is bearish. MACD histogram is below zero at -0.0313 and still negative, RSI_6 is neutral at 54.3, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price is trading around 9.59 after a sharp move, while key resistance sits near 11.64 to 12.32 and support is around 11.22 down to 10.96 based on the provided levels. The pattern data suggests near-term weakness, with an estimated 80% chance of -1.22% over the next day and -0.64% over the next week.
["Q4 FY2026 adjusted EBIT margin came in at 7.6%, showing continued profitability.", "Free cash flow was strong at $110 million in Q4 and $713 million for the year.", "The company repurchased $250 million in shares, supporting shareholder returns.", "Financial snapshot shows net income and EPS growth in 2026/Q3 despite lower revenue."]
["Q4 FY2026 revenue fell 6.6% year over year to $3.1 billion.", "Management guided for a 3% to 5% decline in organic revenue for FY2027.", "Expected FY2027 adjusted EBIT margin of 6% to 7% implies softer profitability ahead.", "The company won only 32% of 13 large global contract opportunities, indicating competitive pressure.", "Hedge funds and insiders are both neutral with no notable buying trends.", "No recent politician or congress trading activity was reported."]
Latest reported quarter appears to be Q4 FY2026. Revenue was down 6.6% year over year to $3.1 billion, which is a negative growth signal. On the positive side, adjusted EBIT margin was 7.6%, free cash flow was $110 million for the quarter and $713 million for the year, and the company repurchased $250 million of stock. In 2026/Q3, revenue was 3.194 billion, down 0.96% YoY, while net income rose 87.72% and EPS rose 96.77%, suggesting improved bottom-line efficiency even as top-line growth stayed weak.
TD Cowen lowered its price target on DXC to $14 from $15 and kept a Hold rating. The recent analyst tone is neutral-to-cautious, with expectations for broadly uneventful quarters across the IT services group. Wall Street’s pros are valuation support from cash flow and buybacks, while the cons are declining revenue, weak organic growth outlook, and limited evidence of a strong turnaround.
